Tasmanian Government Apology Sparks Potential Financial Liabilities in Stolen Remains Scandal Texas Roadhouse TXRH Q1 2026 Earnings Beat Revenue NA EPS 187 Fed Leadership Transition Powell and Warsh Set for Historic Policy Clash at June FOMC Meeting Amazons Unchallenged Western Dominance Why No Rival Can Compete Micron Memory Milestone Dicks Earnings Surprise and Texas Primary Upset Lead Todays Market Movers Assessing BP plc BP as a Natural Gas Stock for Transitional Power EU New Car Market 2026 Electric Vehicle Growth and Chinese Carmaker Expansion Highlighted by ACEA Data Fed Minutes Reveal Officials Anticipate Rate Hikes If Inflation Persists Jobless Claims Remain Low Indicating Sustained Labor Market Strength Eli Lilly Edges Higher on Nearly 4B Vaccine Deal Expansion STE Q1 2026 Earnings EPS Miss Amidst Operational Headwinds AptarGroup Q1 2026 Earnings EPS Beats Estimates by 233 Shares Edge Higher ONL Q1 2026 Earnings EPS Misses Estimates Significantly Stock Climbs Modestly Block Inc XYZ Q1 2026 Earnings Strong EPS Beat of 2443 Surprises Markets Shares Dip Slightly RANI Q1 2026 Earnings SmallerThanExpected Loss Drives Positive Stock Reaction PFIS Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short Aurora Mobile JG Slides 895 Key Support Level Under Pressure Phunware Inc PHUN Holds Steady at 202 as Key Support and Resistance Levels Converge Bitcoin Depot BTM Slides 15 as CryptoLinked Shares Face Renewed Pressure Alphatec Holdings ATEC Slips 169 as Stock Tests Key Support Zone BlackRock Municipal 2030 Target Term Trust BTT Inches Higher as Investors Seek TaxExempt Stability PagerDuty Shares Edge Higher as Bulls Test Key Resistance at 756 Rising Dragon Acquisition Corp RDAC Holds Steady Near 969 as SPAC Market Watches for Catalyst West Bancorporation WTBA Edges Lower as Shares Test Key Support Levels AMREP Corporation AXR Edges Higher as Shares Test Near Resistance Telomir Pharmaceuticals TELO Consolidates Near 129 as Support and Resistance Levels Tighten Bond Market Signals Concern as Fed May Fall Behind on Inflation Warsh Era Begins TWAV Q3 2022 Earnings Steep EPS Miss Raises Concerns Over Profitability CanFite Biopharma CANF Slides 262 Toward 318 Support as Selling Pressure Persists